Is a Synthetic Peptide the Same Molecule as the Natural One?
Match the sequence and the two are the same thing. That claim holds at the level of letters written on a page and starts failing the moment you look at what is physically in a vial. Where the natural molecule carries an amidated C-terminus and the synthetic one does not, the measured mass will report the discrepancy, and no amount of sequence agreement papers over it. Several such gaps persist, and together they are why anyone bothers drawing the distinction.
Where the two really do coincide
Chains assembled by solid-phase synthesis grow residue by residue out of protected amino acids. Provided each coupling and each deprotection runs to completion, what comes off the resin has precisely the intended sequence, and a mass that matches confirms the elemental composition.
Which means that for something short and unmodified, synthetic material is the same molecule, full stop. Everything discussed below concerns what travels alongside it and what has been omitted from it.
What a cell attaches and a synthesizer does not
Biological peptides emerge from ribosomes and then get processed. Modifications acquired during that processing will not appear in a synthesis unless somebody set out to install them.
| Modification | How it arises |
| Terminal processing | C-terminal amidation happens enzymatically in nature and has to be called for explicitly in a synthesis; N-terminal pyroglutamate can form either way |
| Glycosylation | Sugar chains hung on particular residues, which no standard synthesis produces |
| Phosphorylation, acetylation, hydroxylation | Enzyme-driven and directed to specific sites |
| Disulfide arrangement | Cells fold chains with chaperone help into one defined pairing; synthetic material bearing several cysteines must be oxidized on purpose and may settle into the wrong pattern |
Strip a modification that the natural molecule carries and what remains is a different compound sharing a sequence. Its mass will announce as much.
The surrounding impurities run the opposite way
Chemistry leaves its own signature set of related species: sequences missing a residue where a coupling did not take, truncated chains that stopped extending, material still carrying a protecting group that never came off, and oxidation products picked up during the synthesis or the workup.
Biological production leaves a different set altogether. Misincorporations. Truncations arising from premature termination. Contaminants derived from the host. And virtually nothing traceable to protecting-group chemistry, since none was ever used.
The upshot is that the two production routes can be told apart by what sits around the main peak, even in cases where the main peak itself is one and the same compound. That is one of the ways an impurity profile carries information beyond its own arithmetic.
Handedness
Living systems build with L-amino acids and almost nothing else, a short list of specialized exceptions aside. A synthesizer incorporates whatever was loaded into it, which is how D-residues come to appear routinely throughout designed analogs.
A consequence follows that has no biological counterpart. Racemization is a synthetic worry: some fraction of a residue can flip configuration while it is being coupled, yielding a diastereomer whose mass is indistinguishable. Material of natural origin does not carry that impurity class at all, whereas synthetic material can. The underlying chemistry appears in racemization and chiral purity.
Isotopic signature
Whatever an organism ate determines the isotopic makeup of the carbon in its tissues. Carbon reaching a synthetic amino acid instead reflects the feedstock it was manufactured from, frequently petrochemical in origin.
That difference is slight and changes no chemical behavior, yet isotope ratio mass spectrometry can measure it, and it provides the basis on which material is occasionally traced back to a biological or a synthetic source. Nothing about it belongs to routine characterization.
The fragment problem sits apart
A good many compounds labeled endogenous are pieces cut out of a larger natural protein rather than things any organism releases in that form. Take a stretch spanning residues 17 through 23 of a 43-residue protein: in nature it exists only while still embedded in that protein, absent some cleavage event.
Describing such a piece as endogenous therefore says where its sequence was copied from and nothing about any molecule circulating anywhere. The naming habits responsible for the confusion are unpicked in peptide nomenclature, analogs, fragments and salts.
What a confirmation of identity settles
For synthetic material, identity confirmation amounts to a sequence plus a mass, which together establish that the molecule is the one that was intended. They do not establish equivalence to a natural counterpart wherever that counterpart bears modifications, and they leave stereochemistry entirely unaddressed.
Anywhere equivalence to a natural molecule genuinely bears on the work, it has to be shown rather than assumed from sequence agreement. For most laboratory purposes, though, the question worth answering is how the synthetic material itself characterizes, not how it relates to anything biological.
